Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis

Author(s):: Reijm, S.; Brehler, A.S.; Rantapaa-Dahlqvist, S.; Kawakami, A.; Maeda, T.; Kawashiri, S.Y.; Tamai, M.; Woude, D. van der (0000-0001-8121-5879); Toes, R.E.M. (0000-0002-9618-6414)

Published: 2022
Publication type: Article / Letter to editor

Anti-Citrullinated Protein AntibodiesAutoantibodiesArthritisRheumatoid

Date issued: 2022-04-22
Language: English
Publisher: BMJ PUBLISHING GROUP
Is part of: Annals of the Rheumatic Diseases (2022), Vol. 81, no. 9, p. 1332-1334
hdl: 1887/3513117
doi: 10.1136/annrheumdis-2022-222326